Low-dose intraocular tissue plasminogen activator for treatment of postvitrectomy fibrin formation

Am J Ophthalmol. 1990 May 15;109(5):606-7. doi: 10.1016/s0002-9394(14)70700-7.
No abstract available

MeSH terms

  • Fibrin / drug effects*
  • Humans
  • Recombinant Proteins / administration & dosage
  • Retinal Diseases / drug therapy*
  • Retinal Diseases / etiology
  • Retinal Diseases / metabolism
  • Tissue Plasminogen Activator / administration & dosage*
  • Vitrectomy / adverse effects*

Substances

  • Recombinant Proteins
  • Fibrin
  • Tissue Plasminogen Activator